Different antibiotic treatments for group A streptococcal pharyngitis

Area of Science:

• Infectious Diseases
• Pharmacology
• Evidence-Based Medicine

Background:

• Antibiotics provide modest benefits for sore throat treatment.
• Effectiveness increases with confirmed Group A beta-haemolytic streptococci (GABHS) infection.
• Optimal antibiotic choice for GABHS tonsillopharyngitis remains unclear.

Purpose of the Study:

• Compare the efficacy of different antibiotics for GABHS tonsillopharyngitis.
• Assess symptom alleviation, illness duration, relapse rates, and complication prevention.
• Evaluate adverse effects and the risk-benefit profile of antibiotic treatments.

Main Methods:

• Systematic review and meta-analysis of randomized, double-blind trials.
• Searched multiple databases (CENTRAL, MEDLINE, Embase, Web of Science) up to September 2020.
• Assessed risk of bias and certainty of evidence using Cochrane methods and GRADE approach.

Main Results:

• Uncertainty exists regarding symptom resolution differences between cephalosporins/macrolides and penicillin.
• Low-certainty evidence suggests carbacephems may offer better symptom resolution than penicillin in children.
• Insufficient evidence to conclude on other antibiotic comparisons or long-term complications.

Conclusions:

• Current evidence does not strongly support alternatives to penicillin for GABHS tonsillopharyngitis.
• Carbacephems show potential for improved symptom resolution in pediatric cases.
• Further research is needed in low-income countries and Aboriginal communities due to higher complication risks.